Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel in Acromegaly
NCT00517491Phase 2Withdrawn
- Sponsor
- Ipsen
- Start
- May 2008
- Primary completion
- Dec 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of lanreotide in acromegaly, sponsored by Ipsen. Planned start May 2008; status: withdrawn.
02
Drugs
lanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00517491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517491.